Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution
Yonatan Kok, Jenny Nicolopoulos, Con Dolianitis
Topics & Concepts
Hidradenitis suppurativaMedicineDermatologyPathologyDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasMicroscopic Colitis